The role of cerebrospinal fluid and other biomarker modalities in the Alzheimer's disease diagnostic revolution

被引：21
|
作者：
Schindler, Suzanne E. [1 ,2 ]
Atri, Alireza [3 ,4 ,5 ]
机构：
[1] Washington Univ St Louis, Dept Neurol, St Louis, MO 63130 USA
[2] Charles F & Joanne Knight Alzheimer Dis Res Ctr, St Louis, MO 63130 USA
[3] Banner Hlth, Banner Sun Hlth Res Inst, Sun City, AZ USA
[4] Brigham & Womens Hosp, Ctr Brain Mind Med, Dept Neurol, Boston, MA USA
[5] Harvard Med Sch, Boston, MA USA
来源：
NATURE AGING | 2023年 / 3卷 / 05期
关键词：
TAU;
D O I：
10.1038/s43587-023-00400-6
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
A major transformation in dementia diagnosis and care appears imminent and will depend on three major types of biomarkers: molecular imaging, blood-based biomarkers and cerebrospinal fluid biomarkers. Each modality has unique strengths and limitations that suggest its optimal uses in research, clinical trials and clinical diagnosis.
引用
收藏
页码：460 / 462
页数：3
相关论文
共 50 条
  • [21] Cerebrospinal fluid and blood biomarkers in the diagnostic assays of Alzheimer's disease
    Zhang, Liding
    Liang, Xiaohan
    Zhang, Zhihong
    Luo, Haiming
    JOURNAL OF INNOVATIVE OPTICAL HEALTH SCIENCES, 2022, 15 (01)
  • [22] Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients
    Miyo K. Chatanaka
    Ioannis Prassas
    Eleftherios P. Diamandis
    BMC Medicine, 22
  • [23] Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer's disease patients
    Chatanaka, Miyo K.
    Prassas, Ioannis
    Diamandis, Eleftherios P.
    BMC MEDICINE, 2024, 22 (01)
  • [24] Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer's disease
    Adamczuk, Katarzyna
    Schaeverbeke, Jolien
    Vanderstichele, Hugo M. J.
    Lilja, Johan
    Nelissen, Natalie
    Van Laere, Koen
    Dupont, Patrick
    Hilven, Kelly
    Poesen, Koen
    Vandenberghe, Rik
    ALZHEIMERS RESEARCH & THERAPY, 2015, 7
  • [25] Diagnostic of Alzheimer's disease using acoustic characterization of cerebrospinal fluid
    Bierbaum, H
    Körner, C
    Deuschle, M
    Funck, T
    Gan, D
    PROCEEDINGS OF THE 14TH ALZHEIMER EUROPEAN CONFERENCE, 2004, : 27 - 31
  • [26] Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease
    Katarzyna Adamczuk
    Jolien Schaeverbeke
    Hugo M. J. Vanderstichele
    Johan Lilja
    Natalie Nelissen
    Koen Van Laere
    Patrick Dupont
    Kelly Hilven
    Koen Poesen
    Rik Vandenberghe
    Alzheimer's Research & Therapy, 7
  • [27] Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
    Shaw, Leslie M.
    Vanderstichele, Hugo
    Knapik-Czajka, Malgorzata
    Clark, Christopher M.
    Aisen, Paul S.
    Petersen, Ronald C.
    Blennow, Kaj
    Soares, Holly
    Simon, Adam
    Lewczuk, Piotr
    Dean, Robert
    Siemers, Eric
    Potter, William
    Lee, Virginia M. -Y.
    Trojanowski, John Q.
    ANNALS OF NEUROLOGY, 2009, 65 (04) : 403 - 413
  • [28] The Amyloid-β Oligomer Count in Cerebrospinal Fluid is a Biomarker for Alzheimer's Disease
    Wang-Dietrich, Lei
    Funke, Susanne Aileen
    Kuehbach, Katja
    Wang, Kun
    Besmehn, Astrid
    Willbold, Sabine
    Cinar, Yeliz
    Bannach, Oliver
    Birkmann, Eva
    Willbold, Dieter
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 34 (04) : 985 - 994
  • [29] Aβ42 as a Biomarker of Alzheimer's Disease: Is Saliva a Viable Alternative to Cerebrospinal Fluid?
    Boschi, Silvia
    Roveta, Fausto
    Grassini, Alberto
    Marcinno, Andrea
    Cermelli, Aurora
    Ferrandes, Fabio
    Rainero, Innocenzo
    Rubino, Elisa
    BRAIN SCIENCES, 2022, 12 (12)
  • [30] Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer's Disease
    Holtta, Mikko
    Hansson, Oskar
    Andreasson, Ulf
    Hertze, Joakim
    Minthon, Lennart
    Nagga, Katarina
    Andreasen, Niels
    Zetterberg, Henrik
    Blennow, Kaj
    PLOS ONE, 2013, 8 (06):
12345